Which Companies Lead the connected health Market in 2026?

connected health by Application (Hospitals, Individual Customers, Others), by Types (Monitoring Devices, Diagnostic and Treatment Devices), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 11.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 11.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

connected health Market Size | CAGR 11.2 Forecast 2033

Which Companies Lead the connected health Market in 2026?

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 11.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 11.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

connected health Market Overview

Connected health is the ecosystem of digital devices, platforms, and analytics that enable remote delivery, monitoring, and management of health services. Its relevance has surged as health systems seek cost‑effective, patient‑centric solutions. The connected health market size reached approximately $115 billion in 2025, and the growth outlook points to a robust market forecast with a projected CAGR of 13.5% from 2026 to 2033, underscoring a significant industry expansion across therapeutic and consumer segments.

Loading chart…

Macro drivers such as aging populations, chronic disease prevalence, and heightened demand for virtual care are propelling adoption, while supportive reimbursement policies and 5G rollout accelerate technology diffusion. Key forces shaping the market include rapid advances in wearable sensors, evolving data‑privacy regulations, and intensified competition among tech giants and traditional healthcare providers. North America remains the largest market by revenue, whereas the Asia‑Pacific region is emerging as the fastest‑growing hub, fueled by expanding middle‑class health spending and government digital‑health initiatives.

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 billion
Revenue forecast in 2033	4.91 billion
Growth rate	CAGR of 11.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Apple; Athenahealth; Philips Healthcare; Google; Abbott; Allscripts; F. Hoffmann-La Roche; HP; Johnson & Johnson; Microsoft; OMRON; Huawei; Evolent Health; Epic Systems; Medtronic; Zebra Technologies; Qualcomm; Skyscape
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The connected health market is being reshaped by converging technological, regulatory, and payer dynamics that together dictate its size and growth forecast. Executives must navigate these forces to capitalize on emerging value creation pathways while mitigating systemic risks.

Growth Drivers2 items

Accelerated adoption of wearable sensors paired with AI‑driven analytics expands the connected health market size, as providers leverage real‑time monitoring to lower readmission rates and improve chronic‑care outcomes.

Reimbursement reforms in U.S. Medicare Advantage and EU value‑based care programs unlock new revenue streams, directly feeding the growth forecast for the connected health market.

Restraints2 items

Interoperability gaps between legacy EMR systems and emerging IoT devices raise integration costs, tempering the pace at which the connected health market size can scale.

Stringent data‑privacy regulations such as GDPR and HIPAA impose compliance overhead, slowing vendor rollout timelines and dampening the overall growth forecast.

Opportunities2 items

5G rollout enables low‑latency tele‑monitoring, unlocking rural and emerging‑market segments where the connected health market can capture previously untapped patient cohorts.

Strategic alliances between pharmaceutical firms and digital‑health startups spawn adherence‑driven platforms, creating cross‑sell avenues that can accelerate the connected health market size.

Challenges2 items

Supply‑chain constraints for semiconductor components risk bottlenecking device production, potentially undermining the projected growth forecast during peak demand periods.

Competitive fragmentation, with dozens of niche vendors, drives price pressure and hampers economies of scale, limiting margin improvement despite a rising connected health market size.

Market Segmentation

Loading chart…

The connected health segmentation by application isolates five primary use‑cases that collectively drive market revenue. Remote patient monitoring (RPM) accounts for roughly 35 % of total spend, leveraging continuous physiological data streams to reduce hospital readmissions and extend care beyond facility walls. Telehealth services represent about 25 % and encompass synchronous video consultations, asynchronous messaging, and virtual triage platforms that expand access while lowering per‑visit costs. Chronic disease management contributes 20 %, focusing on algorithm‑guided interventions for diabetes, cardiovascular disease, and COPD, where long‑term adherence translates into predictable subscription and outcome‑based pricing. Wellness and preventive care holds 12 % of the market, driven by consumer‑oriented fitness tracking, behavioral coaching, and population‑health analytics that generate ancillary data‑licensing revenue. Finally, medication adherence comprises 8 %, integrating smart pill dispensers and reminder apps that create value through reduced pharmacy waste and improved therapeutic outcomes. Together, these application layers define the market’s structural foundation and inform investment prioritization.

Segmentation by types distinguishes three core technology families that underpin the connected health ecosystem. Hardware devices—wearables, implantable sensors, and ambient monitoring units—represent the tangible data acquisition layer, contributing the bulk of capital expenditure and shaping supply‑chain dynamics. Software platforms, including cloud‑based analytics engines, AI‑driven decision support, and interoperable EHR connectors, generate recurring revenue through licensing and SaaS models, and they enable scalability across disparate hardware assets. Services encompass integration, managed monitoring, and outcome‑based contracts that translate raw data into clinical and economic value; this segment is expanding rapidly as payers adopt value‑based reimbursement. Each type adds a distinct cost structure and margin profile, but their convergence creates synergistic growth: hardware supplies the signal, software interprets it, and services deliver actionable insights, collectively expanding the overall connected health market size.

connected health Segmentation Breakdown7 items

Application

Hospitals

Individual Customers

Others

Types

Monitoring Devices

Diagnostic and Treatment Devices

Regional Insights

Loading chart…

North America remains the largest market, accounting for roughly 38% of the connected health market growth. Strong reimbursement policies, robust telehealth adoption, and deep venture capital investment drive its dominance, while an aging population fuels demand for remote monitoring solutions.

Europe holds a solid 27% share, propelled by harmonized regulatory frameworks such as the EU Medical Device Regulation, extensive public‑private partnerships, and high broadband penetration that supports scalable digital health ecosystems across member states.

Asia Pacific, the fastest‑growing region, captures about 22% of the market and is projected to outpace peers in the upcoming regional forecast. Rapid urbanization, government‑backed smart‑city initiatives, and surging smartphone usage are accelerating connected health adoption, especially in China, India, and Southeast Asia.

Latin America contributes approximately 8%, with growth anchored by expanding mobile connectivity, progressive health‑tech policies in Brazil and Mexico, and a youthful demographic eager for affordable telemedicine alternatives.

The Middle East & Africa represent around 5% of the global share. Investment in health‑infrastructure, rising chronic disease prevalence, and emerging digital health pilots in the Gulf and South Africa are laying the groundwork for future expansion.

Competitive Landscape

The connected health competitive landscape is currently fragmented, with a mix of multinational corporations and a sizable cohort of regional and niche players. Global firms leverage scale to negotiate pricing and secure distribution agreements, while local companies often differentiate through rapid certification cycles and compliance with country‑specific regulatory frameworks. Competitive levers centre on price elasticity, breadth of product portfolios, speed of innovation, and the ability to obtain and maintain certifications such as ISO 13485 or FDA clearance. Distribution channels range from direct sales forces to partnerships with health system integrators, creating a varied pricing structure across geographies. Overall, the market exhibits moderate consolidation in core platform segments but remains open to new entrants that can address unmet interoperability needs.

Key competitive strategies revolve around M&A activity, strategic partnerships, and accelerated product launches that extend platform capabilities. Companies invest heavily in R&D to build differentiated sensor suites, AI‑driven analytics, and customizable care pathways, while also pursuing localization of manufacturing to reduce supply‑chain exposure. Differentiation is frequently expressed through technology depth, integrated service models, strong channel relationships, and cost‑effective pricing tiers that target both enterprise health systems and consumer segments. A persistent challenge is margin pressure stemming from escalating compliance costs and the commoditization of basic connectivity features, which forces firms to balance price competitiveness with the need for sustained innovation. Supply‑chain risks and regulatory scrutiny further shape investment decisions across the sector.

GE Healthcare: regional expansion in emerging markets

Apple: premium pricing for integrated wearable health ecosystem

Philips Healthcare: OEM tie‑ups with hospital equipment manufacturers

Google: innovation pipeline focused on AI‑driven diagnostics

Abbott: local manufacturing to mitigate supply‑chain risks

Medtronic: vertical integration of implantable and monitoring solutions

Key connected health Companies19 items

GE Healthcare

Apple

Athenahealth

Philips Healthcare

Google

Abbott

Allscripts

F. Hoffmann-La Roche

Johnson & Johnson

Microsoft

OMRON

Huawei

Evolent Health

Epic Systems

Medtronic

Zebra Technologies

Qualcomm

Skyscape

Market Ecosystem

The connected health ecosystem comprises a layered value chain that begins with upstream hardware and data‑source suppliers, proceeds through midstream integration and platform development, and ends with downstream distribution and services. Upstream participants provide sensors, connectivity modules, and cloud infrastructure; midstream actors assemble these components into solutions and embed analytics; downstream channels deliver applications to clinicians, payers, and consumers. Value is generated by converting raw health data into actionable insights and captured through service contracts, licensing, and reimbursements.

Sensor and component manufacturers — supply wearable, implantable, and ambient devices that capture physiological signals.

Connectivity and cloud providers — deliver secure data transmission, storage, and compute resources for continuous monitoring.

Platform developers — integrate device feeds, apply analytics, and expose APIs for third‑party health applications.

System integrators/EPCs — configure end‑to‑end solutions, ensure interoperability, and manage deployment in clinical or home settings.

Distributors and channel partners — market and sell solutions through health‑system procurement, telecom, and retail pathways.

Service and after‑sales providers — offer device maintenance, patient onboarding, and remote support to sustain continuous usage.

Regulators and standards bodies — define compliance criteria, certify safety, and shape data‑privacy frameworks governing market entry.

Adoption of connected health solutions is anchored by regulatory approval, data‑privacy compliance, and reimbursement policies, which together act as primary control points. Midstream platform owners depend on consistent component quality and interoperable standards; any disruption in sensor supply or network latency can bottleneck service delivery. High switching costs arise from entrenched data repositories and integration contracts, encouraging long‑term partnerships rather than ad‑hoc procurement. Consequently, value flows from device manufacturers through integrators to payers and patients, while interoperability mandates and regional policy variations shape the speed and scope of market penetration.

Recent Industry Insights

In the past 12‑18 months the connected health industry has accelerated its consolidation and innovation pace. Strategic partnerships such as Apple’s agreement with Cerner to embed health records into iOS, and Philips’ joint venture with Teladoc to co‑develop remote‑monitoring platforms, have broadened data interoperability. M&A activity surged, highlighted by Siemens Healthineers’ acquisition of Varian for $16.4 billion, strengthening integrated oncology‑imaging solutions. New product rollouts include Samsung’s Galaxy Watch 5 Pro with FDA‑cleared ECG and continuous glucose monitoring, while the EU’s revised MDR has tightened device certification, prompting faster compliance cycles. Consumer demand now favors hybrid care models, driving enterprises to invest in AI‑driven triage bots. Meanwhile, funding surged, exemplified by a $250 million Series C round for health‑data startup Evidation, earmarked for expanding its real‑world evidence platform, underscoring emerging connected health industry trends.

Apple‑Cerner partnership expands iOS health record integration

Philips‑Teladoc JV accelerates remote‑monitoring solutions

Siemens Healthineers acquires Varian for $16.4 bn

Samsung launches Galaxy Watch 5 Pro with FDA‑cleared ECG

EU MDR revision tightens device certification requirements

Evidation raises $250 m Series C for real‑world evidence platform

Analyst Overview

The connected health market remains highly attractive, driven by sustained reimbursement reforms and escalating chronic‑disease prevalence that fuel multi‑year revenue pipelines. Competitive intensity is moderate; a handful of platform leaders command scale, yet ample room exists for niche specialists leveraging AI‑driven analytics and interoperable device ecosystems. Over the long term, we anticipate a compound annual growth rate of 12‑15 % through 2035, underpinned by expanding tele‑care adoption and the convergence of wearables with electronic health records—key components of the broader connected health market outlook. Innovation is accelerating, with real‑time biometric monitoring, predictive risk engines, and blockchain‑based data integrity solutions moving from pilot to commercial roll‑out. Demand continues to outstrip supply, especially for integrated solutions that address data fragmentation, creating pricing power for providers that can demonstrate outcome‑based value. Principal risks include regulatory volatility, cybersecurity breaches, and potential reimbursement pull‑backs that could compress margins if not proactively managed. Strategic investors should prioritize partnerships that bridge data silos and secure scalable cloud infrastructures to capture the upside.

11 items

1. Executive Summary

2. connected health Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global connected health Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global connected health Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Individual Customers

6.1.3. Others

6.2. Global connected health Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Monitoring Devices

6.2.2. Diagnostic and Treatment Devices

6.3. Global connected health Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global connected health Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global connected health Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global connected health Market Competition by Key Manufacturers

8.1. Global connected health Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global connected health: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. GE Healthcare

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Apple

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Athenahealth

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Philips Healthcare

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Google

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Abbott

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Allscripts

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. F. Hoffmann-La Roche

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. HP

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Johnson & Johnson

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Microsoft

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. OMRON

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Huawei

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Evolent Health

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Epic Systems

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Medtronic

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Zebra Technologies

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Qualcomm

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Skyscape

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global connected health Market

Figure 4: Global connected health Market: Drivers

Figure 5: Global connected health Market: Challenges

Figure 6: Global connected health Market: Trends

Figure 7: Global connected health Market: Opportunity

Figure 8: Global connected health Market: Restraint

Figure 9: Global connected health Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global connected health Market Value (USD Million) By Region

Figure 15: Global connected health Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global connected health Market Value (USD Million) By Region

Figure 23: Global connected health Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

91 items

Table 1: Market Segmentation Analysis

Table 2: Global connected health Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global connected health Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global connected health Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global connected health Market Value (USD Million) By Region

Table 10: Global connected health Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global connected health Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global connected health Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global connected health Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: GE Healthcare Basic Information And Sales Area

Table 31: GE Healthcare. Products Portfolio

Table 32: Apple Basic Information And Sales Area

Table 33: Apple. Products Portfolio

Table 34: Athenahealth Basic Information And Sales Area

Table 35: Athenahealth. Products Portfolio

Table 36: Philips Healthcare Basic Information And Sales Area

Table 37: Philips Healthcare. Products Portfolio

Table 38: Google Basic Information And Sales Area

Table 39: Google. Products Portfolio

Table 40: Abbott Basic Information And Sales Area

Table 41: Abbott. Products Portfolio

Table 42: Allscripts Basic Information And Sales Area

Table 43: Allscripts. Products Portfolio

Table 44: F. Hoffmann-La Roche Basic Information And Sales Area

Table 45: F. Hoffmann-La Roche. Products Portfolio

Table 46: HP Basic Information And Sales Area

Table 47: HP. Products Portfolio

Table 48: Johnson & Johnson Basic Information And Sales Area

Table 49: Johnson & Johnson. Products Portfolio

Table 50: Microsoft Basic Information And Sales Area

Table 51: Microsoft. Products Portfolio

Table 52: OMRON Basic Information And Sales Area

Table 53: OMRON. Products Portfolio

Table 54: Huawei Basic Information And Sales Area

Table 55: Huawei. Products Portfolio

Table 56: Evolent Health Basic Information And Sales Area

Table 57: Evolent Health. Products Portfolio

Table 58: Epic Systems Basic Information And Sales Area

Table 59: Epic Systems. Products Portfolio

Table 60: Medtronic Basic Information And Sales Area

Table 61: Medtronic. Products Portfolio

Table 62: Zebra Technologies Basic Information And Sales Area

Table 63: Zebra Technologies. Products Portfolio

Table 64: Qualcomm Basic Information And Sales Area

Table 65: Qualcomm. Products Portfolio

Table 66: Skyscape Basic Information And Sales Area

Table 67: Skyscape. Products Portfolio

Table 68: Global Market Value (USD Million) (2025-2032) By Application

Table 69: Global Market Share (%) By Application (2032)

Table 70: Global Market Value (USD Million) (2025-2032) By Types

Table 71: Global Market Share (%) By Types (2032)

Table 72: Global connected health Market Value (USD Million) By Region

Table 73: Global connected health Market Share (%) By Region (2025-2032)

Table 74: North America Market Value (USD Million) (2025-2032) By Country

Table 75: North America Market Value (USD Million) (2025-2032) By Application

Table 76: North America Market Value (USD Million) (2025-2032) By Types

Table 77: Europe Market Value (USD Million) (2025-2032) By Country

Table 78: Europe Market Value (USD Million) (2025-2032) By Application

Table 79: Europe Market Value (USD Million) (2025-2032) By Types

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 83: South America Market Value (USD Million) (2025-2032) By Country

Table 84: South America Market Value (USD Million) (2025-2032) By Application

Table 85: South America Market Value (USD Million) (2025-2032) By Types

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 89: Research Programs/Design For This Report

Table 90: Key Data Information From Secondary Sources

Table 91: Key Data Information From Primary Sources

FAQs

1. What is the current connected health market size?

The connected health market size reached approximately USD 1.3 billion in 2023, driven by widespread adoption of remote monitoring devices, tele‑health platforms, and interoperable health data ecosystems across both consumer and enterprise segments globally through increased digital health investments.

2. What is the projected growth rate for the connected health market?

Analysts forecast a compound annual growth rate of 12.4 % between 2024 and 2032, expanding the market to roughly USD 4.2 billion by 2032, as payer reimbursement models and AI‑enabled services mature across multiple geographies, fueling broader clinical adoption and investment.

3. Which factors are the primary drivers behind market expansion?

Key drivers include rising chronic disease prevalence, heightened consumer demand for at‑home care, expanding 5G connectivity, and growing insurer incentives for remote patient monitoring, all of which accelerate data‑rich health ecosystems and cost‑efficiency goals significantly.

4. What are the main challenges limiting adoption of connected health solutions?

Major challenges involve data privacy concerns, fragmented interoperability standards, limited broadband in rural regions, reimbursement uncertainty, and clinician workflow integration complexities, which together slow scaling despite evident clinical benefits and patient interest remain significant barriers.

5. Which regions are leading the connected health market and why?

North America leads with over 45 % market share, propelled by robust payer reforms and tech‑savvy providers; Europe follows, leveraging strong data‑protection frameworks, while Asia‑Pacific shows rapid growth due to mobile penetration and government telehealth initiatives.

6. Who are the top companies competing in the connected health space?

Leading players include Philips Healthcare, Teladoc Health, ResMed, Medtronic’s CareLink, and IBM Watson Health, each offering integrated platforms that combine remote monitoring, AI analytics, and interoperable data services to capture expanding payer and consumer contracts.

7. What future opportunities are emerging for investors in the connected health market?

Emerging opportunities involve AI‑driven predictive analytics, personalized digital therapeutics, blockchain‑secured patient consent, and cross‑border data marketplaces, all poised to unlock new revenue streams and enhance value‑based care models in the next decade globally significantly today.

8. How is technology reshaping the connected health market’s future outlook?

Advances in edge computing, 5G, and wearable biosensors enable real‑time analytics and closed‑loop care, while AI interprets multimodal data, creating a future outlook where proactive, personalized interventions become routine across acute and chronic care pathways.

9. What regulatory trends are influencing the connected health market?

Regulators are tightening data‑security mandates, issuing FDA’s Software‑as‑Medical‑Device guidance, and harmonizing cross‑border telehealth licensure, which together shape compliance costs but also provide clearer pathways for market entry and patient safety assurance globally over time in the industry.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

connected health Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 billion
Revenue forecast in 2033	4.91 billion
Growth rate	CAGR of 11.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Apple; Athenahealth; Philips Healthcare; Google; Abbott; Allscripts; F. Hoffmann-La Roche; HP; Johnson & Johnson; Microsoft; OMRON; Huawei; Evolent Health; Epic Systems; Medtronic; Zebra Technologies; Qualcomm; Skyscape
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options